Aristides Capital LLC Purchases New Holdings in Myomo, Inc. (NYSEAMERICAN:MYO)

Aristides Capital LLC acquired a new stake in Myomo, Inc. (NYSEAMERICAN:MYO - Free Report) in the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm acquired 200,000 shares of the company's stock, valued at approximately $1,288,000. Aristides Capital LLC owned approximately 0.66% of Myomo at the end of the most recent reporting period.

Several other hedge funds and other institutional investors have also recently bought and sold shares of the company. Barclays PLC acquired a new position in Myomo during the third quarter worth about $36,000. Jane Street Group LLC purchased a new stake in Myomo in the 3rd quarter valued at approximately $65,000. Thompson Davis & CO. Inc. purchased a new stake in Myomo in the 4th quarter valued at approximately $181,000. Calamos Advisors LLC acquired a new stake in Myomo during the 4th quarter valued at $189,000. Finally, Russell Investments Group Ltd. purchased a new position in Myomo during the fourth quarter worth $229,000. 44.99% of the stock is owned by institutional investors and hedge funds.

Insiders Place Their Bets

In other Myomo news, insider Micah Mitchell sold 48,000 shares of Myomo stock in a transaction that occurred on Friday, March 14th. The shares were sold at an average price of $5.16, for a total transaction of $247,680.00. Following the transaction, the insider now directly owns 140,572 shares of the company's stock, valued at $725,351.52. The trade was a 25.45 % decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is accessible through this hyperlink. Also, insider Harry Kovelman sold 30,000 shares of the stock in a transaction on Wednesday, March 12th. The stock was sold at an average price of $5.50, for a total transaction of $165,000.00. Following the completion of the sale, the insider now directly owns 97,973 shares of the company's stock, valued at $538,851.50. The trade was a 23.44 % decrease in their position. The disclosure for this sale can be found here. 4.54% of the stock is currently owned by insiders.

Myomo Price Performance

Shares of MYO stock traded up $0.05 during trading hours on Friday, hitting $4.34. 527,890 shares of the company were exchanged, compared to its average volume of 342,647. Myomo, Inc. has a 1 year low of $2.51 and a 1 year high of $7.17. The firm has a market cap of $131.13 million, a P/E ratio of -18.85 and a beta of 1.68.

Wall Street Analyst Weigh In

MYO has been the topic of a number of analyst reports. Ascendiant Capital Markets increased their price objective on Myomo from $9.00 to $11.00 and gave the company a "buy" rating in a research note on Monday, March 17th. Craig Hallum raised their price target on shares of Myomo from $9.00 to $11.00 and gave the stock a "buy" rating in a research note on Tuesday, March 11th. HC Wainwright boosted their price objective on shares of Myomo from $7.50 to $9.50 and gave the company a "buy" rating in a research report on Wednesday, March 12th. Finally, Alliance Global Partners restated a "buy" rating on shares of Myomo in a research report on Tuesday, March 11th. Five analysts have rated the stock with a buy rating, Based on data from MarketBeat, Myomo presently has a consensus rating of "Buy" and an average target price of $9.75.

Myomo Company Profile

Myomo, Inc, a wearable medical robotics company, designs, develops, and produces myoelectric orthotics for people with neuromuscular disorders in the United States, China, Germany, and internationally. The company offers MyoPro, a myoelectric-controlled upper limb brace or orthosis product used for supporting a patient's weak or paralyzed arm to enable and improve functional activities of daily living.